Where To Inject Allergy Shots: Clinical Site, Technique, and Protocol
Inject allergy shots subcutaneously into the upper outer arm — posterolateral aspect of the deltoid — alternating arms each visit, with a 26G or 27G ½-inch needle on a 1-mL tuberculin syringe (Cox 2011 PP3, Summary Statements 13-14; ACAAI guidance). Never IM, never intradermal. Aspiration before injection no longer universally required (Summary Statement 61). Mandatory 30-minute post-injection observation.
5 peer-reviewed sources
Inject allergy shots subcutaneously into the posterolateral upper arm (26-27G ½-inch needle, 1-mL tuberculin syringe, alternating arms, 0.05-0.5 mL per dose). Never IM. Aspiration no longer required. 30-minute observation mandatory.
The essentials
Allergy shots are injected subcutaneously into the upper outer arm — the posterolateral aspect of the deltoid region — using a 26G or 27G ½-inch needle on a 1-mL tuberculin syringe, alternating arms each visit per Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034, Summary Statements 13-14) and ACAAI administration guidance. Some clinic protocols use a 27G × ⅜-inch needle for very lean patients.
Four operational decisions for every injection:
1. Site: Upper outer arm, posterolateral to the deltoid, approximately 2-4 cm below the acromion. Avoid the medial arm (brachial artery and nerve), the deltoid tuberosity, and the bicipital groove. Sufficient subcutaneous fat depth must be present.
2. Route: Subcutaneous (SC), never intramuscular (IM), never intradermal. IM delivery into the deltoid increases systemic allergen absorption rate because muscle is more vascularized than subcutaneous fat, elevating systemic reaction risk. Intradermal route (CPT 95024) is reserved for diagnostic skin testing, not immunotherapy.
3. Needle and volume: 26G or 27G ½-inch, 1-mL tuberculin syringe (ACAAI administration guidance). Volume ranges: 0.05, 0.10, 0.15 ... 0.50 mL build-up ladder per Cox 2011 PP3. The 0.5 mL maintenance dose is a representative end-dose; individual clinic protocols may vary based on extract concentration.
4. Laterality: Alternate arms each visit (Summary Statement 14). Track which arm was used at each visit in the clinic record.
With Curex's at-home SCIT program ($129/mo), the inject-where question has the same anatomical answer — posterolateral upper arm, SC, 26-27G ½-inch needle — but the inject-where-location answer changes to the patient's own home. A personalized serum is sterile-compounded to USP <797> standards; a prescribed epinephrine auto-injector must be confirmed on hand before the first dose; and the first injection and every dose change are supervised live over Zoom by the prescribing physician.
Two technique nuances that clinical learners ask about:
Aspiration before injection: no longer universally required per Cox 2011 PP3 Summary Statement 61. Previously, aspiration (pulling back the plunger to check for blood before injecting) was recommended to avoid inadvertent intravascular delivery. Statement 61 updated this — subcutaneous injection technique at the posterolateral deltoid carries minimal intravascular risk, and aspiration is no longer the standard of care.
Pinch technique: pinch the subcutaneous fat with thumb and forefinger, insert the needle at 90° (or 45° for very lean patients). Standard SC injection technique. Release the pinch before delivering the extract to avoid delivering into compressed tissue.
Pre-injection screening before every injection: current symptoms, asthma control (peak flow in asthmatics), new medications (beta-blockers, ACE inhibitors), pregnancy status, fever (Cox 2011 PP3; 86% of US clinics always screen, Epstein 2013, PMID 23535092).
Post-injection: a 30-minute observation period is recommended — approximately 70% of severe systemic reactions begin within this window (Cox 2011 PP3, Summary Statement 32). On Zoom-supervised doses (first injection and every dose change), the prescribing physician observes directly; on established maintenance doses at home, the patient self-monitors and contacts the care team for any emerging symptoms. WAO 5-grade systemic reaction grading (Cox L, Larenas-Linnemann D, JACI 2010) should be used to document any reaction. Local reaction rate: 78.3% of patients at least once; 16.3% per injection (LOCAL study, Calabria CW, Tankersley MS, JACI 2009, PMID 19767075).
UnitedHealthcare ended coverage of unmonitored home SCIT January 1, 2023. Curex's at-home SCIT model — with allergist-directed care, Zoom-supervised dosing, and prescribed epinephrine on hand — provides the supervised structure that makes safe home self-administration possible for eligible patients.
How allergy shots retrain your immune system
The subcutaneous injection site at the posterolateral deltoid delivers allergen extract into a fat depot with controlled absorption kinetics. The tissue's lower vascularity compared to muscle produces slow, steady allergen release — enabling antigen-presenting dendritic cells in the subcutaneous tissue to process the extract and present allergen peptides to T lymphocytes in regional lymph nodes under non-inflammatory conditions. This environment is necessary for FOXP3+ regulatory T-cell differentiation and IgG4 class-switching — the molecular mechanisms of tolerance induction. Intramuscular delivery would accelerate allergen entry into the systemic circulation, potentially triggering IgE-mediated mast cell degranulation before the regulatory response can be established.
Pre-injection screening
Screen for current symptoms, asthma control, peak flow in asthmatics, new medications (beta-blockers, ACE inhibitors), fever, pregnancy status. Postpone and notify allergist if asthma is uncontrolled or significant symptom worsening is present.
Verify dose and draw up
Verify the prescribed dose against the correct vial (check label, lot number, expiry). Draw the ordered volume (0.05-0.5 mL) into a 1-mL tuberculin syringe with a 26G or 27G ½-inch needle. Record dose, vial lot, and which arm will receive the injection.
Inject subcutaneously into posterolateral deltoid
Identify the posterolateral deltoid zone (~2-4 cm below the acromion, outer posterior arm). Pinch SC fat with thumb and forefinger. Insert needle at 90° (45° for lean patients). Aspiration no longer universally required (Cox 2011 PP3, Summary Statement 61). Deliver extract slowly. Remove needle, apply light pressure without rubbing.
Document and observe 30 minutes
Document: arm used, dose, lot number, time of injection, pre-injection screen findings. Patient observes for 30 minutes. Grade and document any reactions using WAO 5-grade system. Note opposite arm for next visit.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Why is aspiration no longer required before allergy shot injection?
Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, Summary Statement 61) updated the practice parameter to state that aspiration before subcutaneous injection is no longer universally required. The original rationale for aspiration was to avoid inadvertent intravascular injection of allergen extract, which could cause rapid systemic allergen delivery. However, the posterolateral deltoid injection site carries minimal intravascular risk — there are no large vessels in the standard SC injection zone, and the 26-27G ½-inch needle is short enough that it rarely reaches deeper vascular structures. Standardizing away from mandatory aspiration also reduces injection-time discomfort slightly. Individual clinic protocols may still include aspiration as a precautionary step — this is a permitted but no-longer-required deviation from the guideline.
What is the correct injection technique for allergy shots?
The correct technique for subcutaneous allergy shot injection is: (1) Identify the posterolateral deltoid zone, approximately 2-4 cm below the acromion on the outer posterior upper arm. (2) Clean the site with an alcohol swab and allow to dry. (3) Pinch the subcutaneous fat with the non-dominant thumb and forefinger to lift the fat away from the muscle. (4) Insert the 26G or 27G ½-inch needle at 90° to the skin (45° for very lean patients) in a swift, smooth motion. (5) Release the pinch. (6) Slowly depress the plunger to deliver the prescribed volume (0.05-0.5 mL). (7) Remove the needle in the same angle as insertion. (8) Apply gentle pressure with a cotton ball — do not rub (rubbing can increase local reaction area). (9) Document and begin 30-minute observation.
How deep should the allergy shot needle go?
The needle should penetrate just past the dermis into the subcutaneous fat layer — not into the deltoid muscle. A 26G or 27G ½-inch (12.7 mm) needle at 90° insertion into a typical adult upper arm with a skin pinch typically reaches the subcutaneous fat at approximately 5-8 mm depth. The full ½-inch of the needle need not be completely inserted — penetrate until the bevel is fully within the tissue, then deliver. For very lean patients with minimal subcutaneous fat, a 45° insertion angle or a 27G × ⅜-inch needle reduces the risk of IM penetration. If the patient reports unusual sharpness or burning during injection (suggesting IM delivery), note it, complete the injection, and maintain the full 30-minute observation window with heightened vigilance.
Can I inject both arms at the same visit?
Some high-volume or cluster SCIT protocols deliver multiple injections at a single visit — one per arm, or multiple at one site if the total volume exceeds a single injection's standard volume. Cluster protocols (Tabar AI et al., JACI 2005) give 2-3 injections per visit with a 20-minute interval between each, compressing the build-up phase from 24-28 weeks to 4-8 weeks. Standard conventional SCIT (Cox 2011 PP3) typically gives one injection per visit into one arm. Delivering multiple extracts at one visit — particularly allergens from different biological classes — requires allergist oversight to ensure the combined dose does not exceed safe threshold for the current vial dilution. Any multi-injection visit protocol must be explicitly prescribed and supervised by the allergist.
What if the patient has very little subcutaneous fat in the arm?
For very lean patients with minimal subcutaneous fat at the posterolateral deltoid, consider a 45° insertion angle instead of 90°, or use a shorter needle (27G × ⅜-inch rather than ½-inch). Some allergist protocols permit using the posterior thigh in very lean patients or small children as an alternative subcutaneous site, but this requires explicit allergist authorization. In all cases, the goal is to deliver extract into subcutaneous fat, not muscle — inadvertent IM delivery in lean patients is a recognized risk that increases with perpendicular insertion and long needles. Document any technique modifications and the allergist should be notified if injection site adequacy is a persistent concern.
Does the patient need to stay awake and seated during the injection?
You should be seated or reclined for an allergy shot and stay conscious and able to communicate during the entire 30-minute observation period. A supine (lying-down) position may be preferred if you have a history of vasovagal syncope, to reduce injury risk if fainting occurs. Don't let yourself fall asleep during observation — you need to be able to report any emerging symptoms (throat tightness, generalized itching, difficulty breathing, lightheadedness) to your care team in real time, and on video-supervised doses your care team watches live. If you become minimally responsive or unconscious at any point during the observation window, treat it as a potential systemic reaction until proven otherwise — use your prescribed epinephrine auto-injector and call 911.
Can allergy shots cause scar tissue to form at the injection site?
Long-term, repeated subcutaneous injections at the same site can theoretically cause localized fat atrophy (lipoatrophy) or subcutaneous fibrosis — a risk also seen with insulin and biologic injections at fixed sites. This is one of the clinical reasons Cox 2011 PP3 specifies alternating arms at each visit: distributing injections across both deltoids reduces cumulative trauma and minimizes the risk of chronic local tissue changes at a single site. In standard SCIT practice with proper arm alternation, symptomatic injection-site scarring or fibrosis is not a commonly reported complication. Patients who develop persistent localized induration at an injection site should report it to their allergist for assessment before the next scheduled injection.
Related Articles
Are There Allergy Shots? History and Availability | Curex
Yes — allergy shots exist since 1911 (Noon, Lancet), are FDA-regulated biologics covering grass, ragweed, dust mite, cat, dog, mold, and Hymenoptera venom.
Read moreAre Allergy Shots Painful? | Curex Allergy Shot Guide
Allergy shots use a 26-27G needle (same as insulin) — brief pinch lasting seconds. 78.3% of patients get at least one local arm reaction — itchy, not dangerous.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAre Allergy Shots Permanent? | Curex Allergy Shot Guide
Allergy shots are disease-modifying, not permanent — Durham 1999 NEJM: 3-yr grass SCIT gives 3+ yr remission post-stop. Relapse 0–55% by allergen.
Read moreAllergy Injection: One Visit Explained | Curex
An allergy injection is one step in a 3-to-5-year SCIT course. Learn pre-injection screening, technique, the 30-min observation, and why singular search intent often finds depot steroids instead.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex $129/mo. Not Cytopoint.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.